- ICH GCP
- US Clinical Trials Registry
- Search trials
Clinical Trials on Chronyc Myeloid Leukemia
Total 32714 results
-
Centre Hospitalier Universitaire de NiceUnknownLeukemia, Myelogenous, Chronic, BCR-ABL Positive
-
Asan Medical CenterCompletedLeukemia, Myelogenous, Chronic, BCR-ABL PositiveKorea, Republic of, Canada
-
Bio-Path Holdings, Inc.WithdrawnAcute Myeloid Leukemia | Myelodysplastic Syndrome | Chronic Myelogenous Leukemia, Ph1-PositiveUnited States
-
University of Milano BicoccaIRCCS San RaffaeleCompletedLeukemia | BCR-ABL Positive | Myelogenous | ChronicItaly
-
Foghorn Therapeutics Inc.RecruitingRefractory Acute Myeloid Leukemia | Refractory Chronic Myelomonocytic Leukemia | Relapsed Acute Myeloid Leukemia | Relapsed Myelodysplastic Syndromes | Refractory Myelodysplastic Syndromes | Advanced Hematologic Malignancy | Relapsed Chronic Myelomonocytic LeukemiaUnited States
-
M.D. Anderson Cancer CenterNational Cancer Institute (NCI)CompletedFLT3 Gene Mutation Negative | FLT3 Internal Tandem Duplication Positive | Recurrent Acute Myeloid Leukemia | Recurrent Chronic Myelomonocytic Leukemia | Recurrent Myelodysplastic Syndrome | Refractory Acute Myeloid Leukemia | Refractory Chronic Myelomonocytic Leukemia | Refractory Myelodysplastic...United States
-
Masaryk UniversityActive, not recruitingChronic Myeloid Leukemia, Chronic Phase | Withdrawal;DrugCzechia
-
Novartis PharmaceuticalsCompletedAcute Myeloid Leukemia | Acute Lymphoblastic Leukemia | Philadelphia Positive Chronic Myeloid LeukemiaUnited States, Germany, United Kingdom, France, Italy
-
National Cancer Institute (NCI)CompletedRecurrent Adult Acute Myeloid Leukemia | Adult Acute Myeloid Leukemia With 11q23 (MLL) Abnormalities | Adult Acute Myeloid Leukemia With Inv(16)(p13;q22) | Adult Acute Myeloid Leukemia With t(16;16)(p13;q22) | Adult Acute Myeloid Leukemia With t(8;21)(q22;q22) | Secondary Acute Myeloid Leukemia and other conditionsUnited States
-
Nanfang Hospital of Southern Medical UniversityRecruitingChronic Myeloid LeukemiaChina
-
Fundación Teófilo Hernando, SpainRecruitingChronic Myeloid LeukemiaSpain
-
The University of Hong KongRecruiting
-
University of JenaCompletedChronic Myeloid LeukemiaGermany, Switzerland, Czechia
-
TakedaCompleted
-
Novartis PharmaceuticalsCompleted
-
Tanta UniversityCompletedChronic Myeloid LeukemiaEgypt
-
Gruppo Italiano Malattie EMatologiche dell'AdultoActive, not recruiting
-
Teva Branded Pharmaceutical Products R&D, Inc.TerminatedChronic Myeloid LeukemiaUnited States, Belgium, France, Korea, Republic of
-
University of British ColumbiaBristol-Myers SquibbCompleted
-
Novartis PharmaceuticalsCompletedChronic Myeloid LeukemiaUnited Kingdom, Germany
-
University Health Network, TorontoUnknown
-
Bristol-Myers SquibbCompletedChronic Myeloid LeukemiaAustralia, Italy, Canada, United States, Germany, Spain, France
-
Prof. Dr. Nikolas von BubnoffNovartisTerminated
-
University Health Network, TorontoOzmosis Research Inc.UnknownChronic Myeloid LeukemiaCanada
-
Ankara UniversityUnknownChronic Myeloid LeukemiaTurkey
-
Amsterdam UMC, location VUmcMerck Sharp & Dohme LLC; Novartis; Uppsala University HospitalTerminatedChronic Myeloid LeukemiaNetherlands, Denmark, Sweden, Finland, Norway
-
Poitiers University HospitalCompleted
-
Kanto CML Study GroupEpidemiological and Clinical Research Information NetworkCompletedChronic Myeloid LeukemiaJapan
-
Chia Tai Tianqing Pharmaceutical Group Co., Ltd.CompletedChronic Myeloid LeukemiaChina
-
CttqRuijin HospitalUnknown
-
Hospices Civils de LyonNovartisUnknownChronic Myeloid LeukemiaFrance
-
Herbert Irving Comprehensive Cancer CenterNational Cancer Institute (NCI)Completed
-
Brian LeberUniversity Health Network, TorontoCompletedChronic Myeloid LeukemiaCanada
-
Columbia UniversityTerminatedChronic Myeloid LeukemiaUnited States
-
University of BolognaNovartisCompletedChronic Myeloid LeukemiaItaly
-
University of BolognaNovartis; Schering-PloughTerminated
-
Poitiers University HospitalNovartisCompletedChronic Myeloid LeukemiaFrance
-
Bristol-Myers SquibbCompletedMyeloid Leukemia, ChronicGermany, India, Japan, Korea, Republic of, Turkey, Chile, China, Spain, Australia, France, Poland, Mexico, Colombia, Belgium, Austria, Italy, Peru, Greece, Brazil, Czech Republic, Hungary, Russian Federation, Netherlands, Argentina, Den... and more
-
Sheba Medical CenterWithdrawnChronic Myeloid LeukemiaIsrael
-
M.D. Anderson Cancer CenterNational Cancer Institute (NCI)RecruitingAcute Myeloid Leukemia Arising From Previous Myelodysplastic Syndrome | Chronic Myelomonocytic Leukemia | Myelodysplastic Syndrome | Recurrent Acute Myeloid Leukemia | Refractory Acute Myeloid Leukemia | High Risk Myelodysplastic SyndromeUnited States
-
Rutgers, The State University of New JerseyNational Cancer Institute (NCI)CompletedAcute Myeloid Leukemia | Chronic Myelomonocytic Leukemia | Secondary Acute Myeloid Leukemia | Myelodysplastic Syndrome | Recurrent Acute Myeloid Leukemia | Refractory Acute Myeloid Leukemia | Myeloproliferative Neoplasm | Myeloblasts 10 Percent or More of Bone Marrow Nucleated CellsUnited States
-
National Cancer Institute (NCI)Active, not recruitingChronic Myeloid Leukemia, BCR-ABL1 PositiveUnited States, Canada
-
University of JenaCompleted
-
Novartis PharmaceuticalsCompletedChronic Myeloid LeukemiaUnited States
-
Charite University, Berlin, GermanyTerminated
-
Novartis PharmaceuticalsCompletedChronic Myeloid LeukemiaFrance
-
PfizerCompletedChronic Myeloid LeukemiaUnited States, Canada, Spain, China, Australia, Singapore, Korea, Republic of, France, Hong Kong, Netherlands, Turkey, Poland, Japan, United Kingdom, Argentina, Colombia, Hungary, Russian Federation, South Africa, Belgium, Brazil, Chil... and more
-
Teva Branded Pharmaceutical Products R&D, Inc.Cephalon; ChemGenex PharmaceuticalsCompletedChronic Myeloid LeukemiaUnited States, Canada, France, Germany, Hungary, India, Italy, Poland, Singapore, United Kingdom
-
St. Anna KinderkrebsforschungCompletedChronic Myeloid LeukemiaAustria, Czechia, Italy
-
M.D. Anderson Cancer CenterNovartis PharmaceuticalsUnknown